\-\ Texto\\:\\ \ \(0\)\
\-\ mild\\ wheezes\\ bilaterally\\ in\\ upper\\ lung\\ fields\\,\\ otherwise\\ unremarkable\\ with\\ normal\\ respirator\\ effort\\.\\ sputum\\,\\ blood\\ cultures\\ were\\ negative\\.\\ tb\\ testing\\ negative\\ x\\ 2\\.\ \(0\)\
\-\ 2\\ week\\ follow\\ up\\ with\\ hrct\\ before\\ then\\ to\\ further\\ evaluate\\.\\ no\\ further\\ treatment\\ as\\ patient\\ has\\ completed\\ antibiotic\\ course\\,\\ lesions\\ were\\ determined\\ to\\ be\\ cystic\\ and\\ is\\ asymptomatic\\.\ \(0\)\
\-\ residual\\ pneumonic\\ process\\.\\ lul\\ w\\/\\ multiple\\ cavitations\\.\\ \ \(0\)\
\-\ homogenous\\ mass\\ 3\\.5cm\\ x\\ 4\\.0cm\\ along\\ mid\\ left\\ lateral\\ chest\\ wall\\.\\ \ \(0\)\
\-\ single\\ cavitation\\ 4cm\\ in\\ diameter\\ present\\ in\\ rul\\.\\ \ \(0\)\
\-\ no\\ pleural\\ effusion\\.\\ normal\\ heart\\ size\\.\ \(0\)\
\-\ post\\ inflammatory\\ cystic\\ changes\\ secondary\\ to\\ severe\\ community\\ acquired\\ pneumonia\\.\ \(0\)\
\-\ cystic\\ vs\\.\\ granulomatous\\ lesions\\.\ \(0\)\
\-\ cystic\\:\\ blebs\\,\\ bullae\\,\\ congenital\\ cystic\\ lesions\\,\\ coccidomycosis\\,\\ pcp\\,\\ hydadid\\,\\ traumatic\\ cysts\\.\ \(0\)\
\-\ cavitary\\:\\ neoplastic\\,\\ staph\\,\\ gnr\\,\\ mycobacteria\\,\\ anerobes\\,\\ coccy\\,\\ histo\\,\\ pcp\\,\\ aspergillosis\\,\\ parasites\\,\\ immunologic\\,\\ emboli\\,\\ pmf\\,\\ bronchiectasis\\,\\ congenital\\ lesions\ \(0\)\
\-\ 18\\ yo\\ 6\\ weeks\\ s\\/p\\ acute\\ episode\\ of\\ severe\\ community\\ acquired\\ pneumonia\\ treated\\ with\\ full\\ course\\ of\\ antibiotics\\.\\ patient\\ reported\\ improved\\ symptoms\\ at\\ time\\ of\\ study\\.\ \(0\)\
\-\ 2\\ week\\ follow\\ up\\ with\\ hrct\\ before\\ then\\ to\\ further\\ evaluate\\.\\ no\\ further\\ treatment\\ as\\ patient\\ has\\ completed\\ antibiotic\\ course\\,\\ lesions\\ were\\ determined\\ to\\ be\\ cystic\\ and\\ is\\ asymptomatic\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cystic\\:\\ 0\\.2728704120917797\ \(0\)\
\-\ lesions\\:\\ 0\\.21683743581525267\ \(0\)\
\-\ further\\:\\ 0\\.19672933314178617\ \(0\)\
\-\ hrct\\:\\ 0\\.19638716222053795\ \(0\)\
\-\ community\\:\\ 0\\.1848620188433613\ \(0\)\
\-\ pcp\\:\\ 0\\.1689563964126257\ \(0\)\
\-\ course\\:\\ 0\\.16733193983825892\ \(0\)\
\-\ completed\\:\\ 0\\.15630029158019332\ \(0\)\
\-\ acquired\\:\\ 0\\.1455655120846251\ \(0\)\
\-\ determined\\:\\ 0\\.1438568402913494\ \(0\)\
\-\ antibiotic\\:\\ 0\\.14133348194701204\ \(0\)\
\-\ before\\:\\ 0\\.12209473441380245\ \(0\)\
\-\ respirator\\:\\ 0\\.12076037477477863\ \(0\)\
\-\ coccidomycosis\\:\\ 0\\.12076037477477863\ \(0\)\
\-\ hydadid\\:\\ 0\\.12076037477477863\ \(0\)\
\-\ coccy\\:\\ 0\\.12076037477477863\ \(0\)\
\-\ pmf\\:\\ 0\\.12076037477477863\ \(0\)\
\-\ pneumonia\\:\\ 0\\.11920365871610358\ \(0\)\
\-\ evaluate\\:\\ 0\\.11743798964820285\ \(0\)\
\-\ were\\:\\ 0\\.1167730017902261\ \(0\)\
\-\ gnr\\:\\ 0\\.11539298502699452\ \(0\)\
\-\ anerobes\\:\\ 0\\.11539298502699452\ \(0\)\
\-\ pneumonic\\:\\ 0\\.11158476139585766\ \(0\)\
\-\ congenital\\:\\ 0\\.10851238822595238\ \(0\)\
\-\ then\\:\\ 0\\.10690733779328228\ \(0\)\
\-\ cavitations\\:\\ 0\\.10621737164807354\ \(0\)\
\-\ parasites\\:\\ 0\\.10621737164807354\ \(0\)\
\-\ mycobacteria\\:\\ 0\\.1041767847714882\ \(0\)\
\-\ immunologic\\:\\ 0\\.1041767847714882\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.10281445710919443\ \(0\)\
\-\ blebs\\:\\ 0\\.10240914801693668\ \(0\)\
\-\ histo\\:\\ 0\\.10240914801693668\ \(0\)\
\-\ week\\:\\ 0\\.10157963738120059\ \(0\)\
\-\ bullae\\:\\ 0\\.09598218396803362\ \(0\)\
\-\ staph\\:\\ 0\\.09598218396803362\ \(0\)\
\-\ severe\\:\\ 0\\.09560492072903556\ \(0\)\
\-\ lul\\:\\ 0\\.09500117139256722\ \(0\)\
\-\ cavitation\\:\\ 0\\.09500117139256722\ \(0\)\
\-\ to\\:\\ 0\\.09438945201784181\ \(0\)\
\-\ negative\\:\\ 0\\.09349811776648878\ \(0\)\
\-\ rul\\:\\ 0\\.09243100942168064\ \(0\)\
\-\ aspergillosis\\:\\ 0\\.09167436852136844\ \(0\)\
\-\ effort\\:\\ 0\\.08901796773134799\ \(0\)\
\-\ sputum\\:\\ 0\\.08447819820631285\ \(0\)\
\-\ cavitary\\:\\ 0\\.08287167027914721\ \(0\)\
\-\ follow\\:\\ 0\\.08141521747901956\ \(0\)\
\-\ homogenous\\:\\ 0\\.08014668067288767\ \(0\)\
\-\ wheezes\\:\\ 0\\.07954486740794843\ \(0\)\
\-\ 4cm\\:\\ 0\\.07954486740794843\ \(0\)\
\-\ bronchiectasis\\:\\ 0\\.07896922837184095\ \(0\)\
\-\ up\\:\\ 0\\.07470603528202242\ \(0\)\
\-\ fields\\:\\ 0\\.07427589902000734\ \(0\)\
\-\ emboli\\:\\ 0\\.07407978266383868\ \(0\)\
\-\ patient\\:\\ 0\\.07368093960692154\ \(0\)\
\-\ no\\:\\ 0\\.07366708065170965\ \(0\)\
\-\ treatment\\:\\ 0\\.07194089239115269\ \(0\)\
\-\ cultures\\:\\ 0\\.07112589492933966\ \(0\)\
\-\ neoplastic\\:\\ 0\\.06979361499291997\ \(0\)\
\-\ episode\\:\\ 0\\.06910757485685877\ \(0\)\
\-\ has\\:\\ 0\\.0689835042634505\ \(0\)\
\-\ residual\\:\\ 0\\.06871239291605456\ \(0\)\
\-\ testing\\:\\ 0\\.06783374551227318\ \(0\)\
\-\ tb\\:\\ 0\\.06724003112303405\ \(0\)\
\-\ granulomatous\\:\\ 0\\.06712441805698394\ \(0\)\
\-\ improved\\:\\ 0\\.06700980598242123\ \(0\)\
\-\ normal\\:\\ 0\\.06166221305520916\ \(0\)\
\-\ be\\:\\ 0\\.06126452488582657\ \(0\)\
\-\ diameter\\:\\ 0\\.06068860237824999\ \(0\)\
\-\ as\\:\\ 0\\.06067182517966126\ \(0\)\
\-\ with\\:\\ 0\\.05914489590600617\ \(0\)\
\-\ full\\:\\ 0\\.05902757783957242\ \(0\)\
\-\ single\\:\\ 0\\.058064417744113056\ \(0\)\
\-\ vs\\:\\ 0\\.05760790312871662\ \(0\)\
\-\ traumatic\\:\\ 0\\.05722097252017414\ \(0\)\
\-\ cysts\\:\\ 0\\.05722097252017414\ \(0\)\
\-\ 18\\:\\ 0\\.05722097252017414\ \(0\)\
\-\ pleural\\:\\ 0\\.05684503129775567\ \(0\)\
\-\ process\\:\\ 0\\.05663490606177175\ \(0\)\
\-\ in\\:\\ 0\\.056354920398298355\ \(0\)\
\-\ effusion\\:\\ 0\\.05607369010507338\ \(0\)\
\-\ antibiotics\\:\\ 0\\.055631576630355666\ \(0\)\
\-\ reported\\:\\ 0\\.054387477290676244\ \(0\)\
\-\ mid\\:\\ 0\\.05434357140658241\ \(0\)\
\-\ otherwise\\:\\ 0\\.05382775503709403\ \(0\)\
\-\ heart\\:\\ 0\\.05250489672925315\ \(0\)\
\-\ size\\:\\ 0\\.05112926323571656\ \(0\)\
\-\ inflammatory\\:\\ 0\\.051060674419477474\ \(0\)\
\-\ unremarkable\\:\\ 0\\.05062330565333372\ \(0\)\
\-\ along\\:\\ 0\\.05059025292225688\ \(0\)\
\-\ bilaterally\\:\\ 0\\.050361166158212595\ \(0\)\
\-\ study\\:\\ 0\\.050361166158212595\ \(0\)\
\-\ yo\\:\\ 0\\.047175710794187406\ \(0\)\
\-\ treated\\:\\ 0\\.04702355266010112\ \(0\)\
\-\ lung\\:\\ 0\\.04593491663069305\ \(0\)\
\-\ wall\\:\\ 0\\.04593491663069305\ \(0\)\
\-\ changes\\:\\ 0\\.04563639755398373\ \(0\)\
\-\ weeks\\:\\ 0\\.0452559159055496\ \(0\)\
\-\ secondary\\:\\ 0\\.044757958463987044\ \(0\)\
\-\ time\\:\\ 0\\.044757958463987044\ \(0\)\
\-\ of\\:\\ 0\\.04433218346045078\ \(0\)\
\-\ blood\\:\\ 0\\.043854577135888514\ \(0\)\
\-\ mild\\:\\ 0\\.04280569372469964\ \(0\)\
\-\ is\\:\\ 0\\.04135903331460746\ \(0\)\
\-\ symptoms\\:\\ 0\\.041315973656113995\ \(0\)\
\-\ post\\:\\ 0\\.04108857350365057\ \(0\)\
\-\ acute\\:\\ 0\\.04084918882619755\ \(0\)\
\-\ upper\\:\\ 0\\.040352526139510625\ \(0\)\
\-\ chest\\:\\ 0\\.03985914187950937\ \(0\)\
\-\ present\\:\\ 0\\.03874773925886299\ \(0\)\
\-\ lateral\\:\\ 0\\.037475024144480396\ \(0\)\
\-\ multiple\\:\\ 0\\.03693463842326646\ \(0\)\
\-\ and\\:\\ 0\\.031207324648132164\ \(0\)\
\-\ mass\\:\\ 0\\.02884362736855927\ \(0\)\
\-\ at\\:\\ 0\\.028521896875306433\ \(0\)\
\-\ left\\:\\ 0\\.025758842966527282\ \(0\)\
